Table 3.
Univariate analysis of parameters of patients with high-risk esophageal varices and low-risk esophageal varices
| Parameter | Patients with HEVs, n = 56 | Patients with LEVs, n = 30 | P value |
| PVSA, mm3 | 227.04 ± 76.66 | 183.81 ± 69.10 | < 0.01 |
| PVD, mm | 14.35 ± 2.64 | 12.67 ± 2.58 | < 0.01 |
| SVD, mm | 10.08 ± 3.36 | 8.52 ± 2.67 | 0.02 |
| CTLV, cm3 | 901.95 ± 219.00 | 935.18 ± 299.83 | 0.66 |
| CTSV, cm3 | 917.30 ± 394.37 | 546.00 ± 375.35 | < 0.01 |
| Ratio of liver and spleen volume | 1.18 ± 0.57 | 3.16 ± 5.25 | < 0.01 |
| SSV, cm3 | 177.03 ± 33.41 | 175.34 ± 29.76 | 0.81 |
| SLV, cm3 | 1052.08 ± 151.88 | 1044.40 ± 135.25 | 0.80 |
| Rate of change of liver volume, % | -0.14 ± 0.20 | -0.10 ± 0.29 | 0.68 |
| Rate of change of spleen volume, % | 4.21 ± 2.11 | 2.06 ± 2.07 | < 0.01 |
| Change of liver volume, cm3 | -150.13 ± 224.10 | -109.22 ± 300.13 | 0.56 |
| Change of spleen volume, cm3 | 740.27 ± 382.77 | 370.66 ± 365.27 | < 0.01 |
| Spleen diameter, cm | 15.81 ± 2.67 | 12.67 ± 2.58 | <0.01 |
| ALT, IU/L | 57.68 (15-176) | 40.97 (13-88) | <0.01 |
| AST, IU/L | 36.38 (10-81) | 61.26 (18-164) | <0.01 |
| TBIL, μmol/L | 27.89 (3.5-73.69) | 34.12 (6-119.7) | 0.59 |
| PT in s | 13.69 (9.9-24) | 13.50 (9.1-18.2) | 0.85 |
| TT in s | 20.44 (17.2-27.9) | 20.28 (16.9-23.1) | 0.01 |
| PLT, × 109/L | 57.68 (15-176) | 73.77 (29-159) | 0.05 |
| LSM, kPa | 20.45 (9.4-36.1) | 26.8 (7.6-75) | 0.26 |
P < 0.05 is considered statistically significant. HEVs: High-risk esophageal varices; LEVs: Low-risk esophageal varices; PVSA: Portal vein surface area; PVD: Portal vein diameter; SVD: Splenic vein diameter; CTLV: Actual liver volume measured by CT; CTSV: Actual spleen volume measured by CT; SSV: Standard spleen volume calculated by equation; SLV: Standard liver volume calculated by equation; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; PT: Prothrombin time; TT: Thrombin time; LSM: Liver stiff measurement.